MET Filing
4Filing Date: Jun 11, 2026

METLIFE INC (MET) · Insider Trading (Form 4) SEC Filing

Statement of Changes in Beneficial Ownership

descriptionView SEC Filing
ACC: 0002066326-26-000009open_in_new
Total Value$1.7K
Trades1
Insiders1

Transaction Details

Mumenthaler Christian Stephane
Director·Direct
Grant · Acquire
Common Stock
Shares+20
Price$85.57
Total Value$1.7K
Shares Owned After2.87K
Transaction DateJun 9, 2026
Footnotes ▸

Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Post-Transaction Holdings

Mumenthaler Christian Stephane
SecuritySharesChange
Common Stock2.87K+20 (0.70%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-06-09 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: METLIFE INC (MET) CIK: 0001099219 --- Reporting Owner --- Name: Mumenthaler Christian Stephane CIK: 0002066326 Role: Director --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-06-09 | Code: A (Grant or award) Shares: +20 | Price: $85.57 Total Value: $1,711.40 Shares Owned After: 2,865 | Ownership: D (Direct) Footnotes: [F1] Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. --- Footnotes (Complete Index) --- F1: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. --- Signature --- /s/ /s/ Morgan Keehner-Jones Mayes, Attorney-in-fact (2026-06-11)

keid analysis is for reference only and does not constitute investment advice.